3-46465599-C-CT
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_001321122.2(LTF):c.4+2652dupA variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0042 ( 4 hom., cov: 0)
Consequence
LTF
NM_001321122.2 intron
NM_001321122.2 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.873
Publications
2 publications found
Genes affected
LTF (HGNC:6720): (lactotransferrin) This gene is a member of the transferrin family of genes and its protein product is found in the secondary granules of neutrophils. The protein is a major iron-binding protein in milk and body secretions with an antimicrobial activity, making it an important component of the non-specific immune system. The protein demonstrates a broad spectrum of properties, including regulation of iron homeostasis, host defense against a broad range of microbial infections, anti-inflammatory activity, regulation of cellular growth and differentiation and protection against cancer development and metastasis. Antimicrobial, antiviral, antifungal and antiparasitic activity has been found for this protein and its peptides. Activity against both DNA and RNA viruses has been found, including activity against SARS-CoV-2, and HIV. [provided by RefSeq, Jul 2021]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BS2
High Homozygotes in GnomAd4 at 4 gene
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001321122.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LTF | NM_001321122.2 | c.4+2652dupA | intron | N/A | NP_001308051.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LTF | ENST00000443496.5 | TSL:2 | c.4+2652_4+2653insA | intron | N/A | ENSP00000397427.1 | |||
| LTF | ENST00000498301.1 | TSL:4 | c.4+2652_4+2653insA | intron | N/A | ENSP00000508000.1 |
Frequencies
GnomAD3 genomes AF: 0.00425 AC: 635AN: 149448Hom.: 4 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
635
AN:
149448
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.00423 AC: 633AN: 149532Hom.: 4 Cov.: 0 AF XY: 0.00428 AC XY: 312AN XY: 72822 show subpopulations
GnomAD4 genome
AF:
AC:
633
AN:
149532
Hom.:
Cov.:
0
AF XY:
AC XY:
312
AN XY:
72822
show subpopulations
African (AFR)
AF:
AC:
218
AN:
40706
American (AMR)
AF:
AC:
37
AN:
15112
Ashkenazi Jewish (ASJ)
AF:
AC:
87
AN:
3454
East Asian (EAS)
AF:
AC:
7
AN:
5130
South Asian (SAS)
AF:
AC:
53
AN:
4760
European-Finnish (FIN)
AF:
AC:
21
AN:
9772
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
204
AN:
67336
Other (OTH)
AF:
AC:
5
AN:
2066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
27
54
81
108
135
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.